ZEVRA THERAPEUTICS, INC. — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
This exhibit package contains only standard Sarbanes-Oxley certification forms signed by CEO Neil F. McFarlane and CFO Justin Renz on November 3, 2026, certifying the accuracy of the Q3 2026 10-Q filing and the effectiveness of internal controls. No financial data, business developments, counterparties, dollar amounts, or operational changes are disclosed in these certification exhibits.
Why this rating
Routine SEC compliance certifications with no substantive business information, developments, or financial detail disclosed.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.